Atlas Trials

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

Clinical trial NCT02535806 · TERMINATED

Trial details

NCT number
NCT02535806
Sponsor
Children's Mercy Hospital Kansas City
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Start date
2015-07-01
Primary completion
2017-05-25
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.